Posted on

Mazdutide and Hepatic Metabolism: Glucagon Co-Agonism, Liver Fat, and Energy Expenditure

3D visualization of dual receptor signaling on a hepatocyte membrane promoting lipid metabolism and mitochondrial oxidation.

Mazdutide combines GLP-1 and glucagon receptor agonism to target hepatic lipid clearance, basal energy expenditure, and systemic weight reduction in metabo

Read more Mazdutide and Hepatic Metabolism: Glucagon Co-Agonism, Liver Fat, and Energy Expenditure

Posted on

Mazdutide as a Dual GLP-1/GCGR Agonist: Minto Pyramid Overview of Mechanisms, Clinical Efficacy, and Metabolic Impacts

3D scientific illustration of dual GLP-1 and glucagon receptor agonist Mazdutide molecular interactions

A structured Minto Pyramid analysis of Mazdutide (IBI362), detailing its dual GLP-1 and glucagon receptor agonism, glycemic and weight regulation, and hepa

Read more Mazdutide as a Dual GLP-1/GCGR Agonist: Minto Pyramid Overview of Mechanisms, Clinical Efficacy, and Metabolic Impacts

Posted on

Mazdutide (IBI362): Mechanisms, Clinical Data, and Metabolic Profile of Dual GLP-1/Glucagon Receptor Agonism

3D molecular visualization of Mazdutide dual GLP-1 and glucagon receptor agonist interaction.

An evidence-based scientific overview of Mazdutide (IBI362), evaluating its dual GLP-1 and glucagon receptor co-agonism across in-vitro, preclinical, and h

Read more Mazdutide (IBI362): Mechanisms, Clinical Data, and Metabolic Profile of Dual GLP-1/Glucagon Receptor Agonism